Event
Biotech Dealmaking – Regulatory Considerations for the Next Wave of Development-Stage Transactions – Program and Lunch @ JPM 2026
Monday, January 12, 2026
Event Details
DateMonday, January 12, 2026
11:30 a.m. - 2:30 p.m. PT
For questions, please contact sfevents@sidley.com.
Join members of Sidley's Global Life Sciences team for a lunchtime CLE-accredited program during the JPM Healthcare Conference discussing the latest regulatory trends impacting the next wave of development-stage transactions.
Led by Meena Datta, global co-leader of Sidley's Healthcare practice; Torrey Cope, partner in Sidley's Food Drug and Medical Device (FDMD) practice; and Sally Wagner Partin, partner in Sidley's M&A practice, this session provides keen insights on the considerations driving recent biotech dealmaking. 1 hour CLE credit available.
Contacts
Offices
Related Resources
Capabilities
Suggested News & Insights
U.S. Drug Pricing Year in Review: Reflections on 2025 and Getting Ready for 2026December 12, 2025BIOSECURE Act Included in the FY2026 National Defense Authorization ActDecember 12, 2025Sidley Ranked in Chambers Asia-Pacific 2026December 11, 2025U.S. Drug Pricing Year in Review: Reflections on 2025 and Getting Ready for 2026December 11, 2025What the U.S.–UK Drug Pricing Agreement Reveals About How MFN Drug Policy Could Impact the UK and EUDecember 10, 2025What the U.S.–UK Drug Pricing Agreement Reveals About How MFN Drug Policy Could Impact the UK and EUDecember 10, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory